Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 12, Issue 3, Pages 285-295
Publisher
Informa UK Limited
Online
2013-03-15
DOI
10.1586/erv.13.22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential Production of IL-23 and IL-12 by Myeloid-Derived Dendritic Cells in Response to TLR Agonists
- (2014) R. E. Roses et al. JOURNAL OF IMMUNOLOGY
- Immunotherapy of cancer in 2012
- (2012) John M. Kirkwood et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
- (2012) Anupama Sharma et al. CANCER
- NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
- (2012) R. Muthuswamy et al. CANCER RESEARCH
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
- (2012) David F Stroncek et al. Journal of Translational Medicine
- T-cell therapy at the threshold
- (2012) Carl June et al. NATURE BIOTECHNOLOGY
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Raising the Bar: The Curative Potential of Human Cancer Immunotherapy
- (2012) S. A. Rosenberg Science Translational Medicine
- Advances in the Treatment of Metastatic Melanoma: New Immunomodulatory Agents
- (2012) Mario Sznol SEMINARS IN ONCOLOGY
- Key role of the positive feedback between PGE2and COX2 in the biology of myeloid-derived suppressor cells
- (2012) Nataša Obermajer et al. OncoImmunology
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Suppression of T-cell responses by tumor metabolites
- (2011) Katrin Singer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission
- (2011) Christina S. Chu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy
- (2011) J. Weber et al. CLINICAL CANCER RESEARCH
- Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
- (2011) Pawel Kalinski et al. IMMUNOLOGIC RESEARCH
- Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
- (2011) Takami Sato et al. IMMUNOLOGIC RESEARCH
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- Helper Activity of Natural Killer Cells During the Dendritic Cell-mediated Induction of Melanoma-specific Cytotoxic T Cells
- (2011) Jeffrey L. Wong et al. JOURNAL OF IMMUNOTHERAPY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- PGE2 transiently enhances DC expression of CCR7 but inhibits the ability of DCs to produce CCL19 and attract naive T cells
- (2010) R. Muthuswamy et al. BLOOD
- Adoptive Therapy Using Antigen-Specific T-Cell Clones
- (2010) Cassian Yee CANCER JOURNAL
- Intracellular mechanisms of antigen cross presentation in dendritic cells
- (2010) Sebastian Amigorena et al. CURRENT OPINION IN IMMUNOLOGY
- The dendritic cell–tumor cross-talk in cancer
- (2010) Yuting Ma et al. CURRENT OPINION IN IMMUNOLOGY
- Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cells
- (2010) Christopher Paustian et al. HUMAN IMMUNOLOGY
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Dendritic Cells Induce Regulatory T Cell Proliferation through Antigen-Dependent and -Independent Interactions
- (2010) T. Zou et al. JOURNAL OF IMMUNOLOGY
- Blockade of Programmed Death Ligand 1 Enhances the Therapeutic Efficacy of Combination Immunotherapy against Melanoma
- (2010) S. Pilon-Thomas et al. JOURNAL OF IMMUNOLOGY
- Potency of Mature CD40L RNA Electroporated Dendritic Cells Correlates With IL-12 Secretion by Tracking Multifunctional CD8+/CD28+ Cytotoxic T-cell Responses In Vitro
- (2010) Mark A. DeBenedette et al. JOURNAL OF IMMUNOTHERAPY
- Approval of Provenge Seen As First Step for Cancer Treatment Vaccines
- (2010) V. Brower JNCI-Journal of the National Cancer Institute
- Improved Endpoints for Cancer Immunotherapy Trials
- (2010) A. Hoos et al. JNCI-Journal of the National Cancer Institute
- Development trends for human monoclonal antibody therapeutics
- (2010) Aaron L. Nelson et al. NATURE REVIEWS DRUG DISCOVERY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8+ T cells against prostate cancer cells and defined prostate cancer-specific epitopes
- (2010) Eva Wieckowski et al. PROSTATE
- Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
- (2010) Pawel Kalinski et al. SEMINARS IN IMMUNOLOGY
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer
- (2009) Celestia S. Higano et al. CANCER
- Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines
- (2009) Adam S. Giermasz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
- (2009) A. Ribas et al. CLINICAL CANCER RESEARCH
- The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis
- (2009) Andrea M. Cooper et al. IMMUNOLOGICAL REVIEWS
- PD-1 signaling in primary T cells
- (2009) James L. Riley IMMUNOLOGICAL REVIEWS
- Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells
- (2009) P. B. Watchmaker et al. JOURNAL OF IMMUNOLOGY
- Development of a Potency Assay for Human Dendritic Cells: IL-12p70 Production
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- Maturation Pathways of Dendritic Cells Determine TAP1 and TAP2 Levels and Cross-presenting Function
- (2009) Andrés López-Albaitero et al. JOURNAL OF IMMUNOTHERAPY
- Rethinking therapeutic cancer vaccines
- (2009) NATURE REVIEWS DRUG DISCOVERY
- Combination of CTL-associated Antigen-4 Blockade and Depletion of CD25+Regulatory T Cells Enhance Tumour Immunity of Dendritic Cell-based Vaccine in a Mouse Model of Colon Cancer
- (2009) Asim Saha et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology
- (2008) A. Curti et al. BLOOD
- Therapeutic efficacy of antitumor dendritic cell vaccinations correlates with persistent Th1 responses, high intratumor CD8+ T cell recruitment and low relative regulatory T cell infiltration
- (2008) Gregory Driessens et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
- (2008) K. Gustafsson et al. CANCER RESEARCH
- Ability of Mature Dendritic Cells to Interact with Regulatory T Cells Is Imprinted during Maturation
- (2008) R. Muthuswamy et al. CANCER RESEARCH
- Cancer Immunotherapy by Dendritic Cells
- (2008) Cornelis J.M. Melief IMMUNITY
- Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
- (2008) Je-Jung Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search